SANTA CLARA, Calif., Oct. 20 /PRNewswire-FirstCall/ -- XenoPort, Inc. announced today that it will provide access via the world wide web to its investor presentations at the following healthcare conferences:
-- Rodman & Renshaw 8th Annual Healthcare Conference Tuesday, November 7, 2006 at 4:55 p.m. Eastern Time -- 2006 Credit Suisse Healthcare Conference Wednesday, November 15, 2006 at 1:00 p.m. Eastern Time -- Lazard Third Annual Life Sciences Conference Wednesday, November 29, 2006 at 11:30 a.m. Eastern Time
To access the live presentations via the web, please go to www.XenoPort.com . Please connect to the website at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
The replay of each webcast can be accessed on the XenoPort website for a minimum of one week and will be available approximately 24 hours after the live presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort’s most advanced product candidate, XP13512, has commenced a Phase 3 clinical program for the treatment of restless legs syndrome, or RLS, and has successfully completed a Phase 2a clinical trial for the management of post-herpetic neuralgia, or PHN. XenoPort has also reported positive preliminary results of a Phase 2a clinical trial of its second product candidate, XP19986, in gastroesophageal reflux disease, or GERD patients.
To learn more about XenoPort, please visit the web site at www.XenoPort.com .
NOTE: XenoPort is a trademark of XenoPort, Inc.
XNPT2G
XenoPort, Inc.
CONTACT: Jackie Cossmon of XenoPort, +1-408-616-7220, or ir@XenoPort.com
Web site: http://www.xenoport.com//
